companydata.dkcompanydata.dk

Incyte Biosciences Denmark ApS: Financial statements 2021

CVR: 35818790

Source: annual report 2021, Danish Business Authority

01/01/2021 – 31/12/2021

Incyte Biosciences Denmark ApS (CVR 35818790) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK 5,287,823 and a net result of DKK 268,531 compared with DKK 150,425 the year before. That is a decrease of 2% compared with the year before. Equity in the 2021 report amounted to DKK 945,939. The solvency ratio was 27.5%. The company had 4 employees in the financial year.

Gross Profit
DKK 5,287,823
Profit/Loss
DKK 268,531
Equity
DKK 945,939
Total Assets
DKK 3,442,193
Employees
4

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2021-5.3M269K946K4
2020-5.4M150K677K3
2019-4.8M286K527K3
2018-3M87K241K2
2017-2M47K154K1

Official annual report

View the official annual report directly on the page with a Pro subscription.

Find more companies like Incyte Biosciences Denmark ApS

Build lead lists with filters on industry, geography, size and financials, and export straight to Excel.

Try the lead list generator

Events in 2021

Incyte Biosciences Denmark ApS: The 2020 annual report is outMay 7, 2021

Incyte Biosciences Denmark ApS has published its annual report for 2020. Gross profit came to DKK 5,397,378, and the net result was DKK 150,425.

About Incyte Biosciences Denmark ApS

Incyte Biosciences Denmark ApS is a Danish company of the type Anpartsselskab based in Frederiksberg C, founded in 2014. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named ARIAD PHARMACEUTICALS (DENMARK) ApS. The management consists of Ebba Cecilia Bröms. The board consists of Lee Jason Heeson (chair) and Ebba Cecilia Bröms. The company is owned by Incyte Biosciences International Sàrl. The company has 4 employees (2026). In 2025, the company reported a gross profit of DKK 6,696,586 and a net result of DKK 361,151 compared with DKK 368,873 the year before. Equity in the 2025 report amounted to DKK 2,328,496.

Source: annual report 2025, Danish Business Authority